Literature DB >> 8771176

Progressive neurologic impairment from an arteriovenous malformation vascular steal.

R D Sheth1, J B Bodensteiner.   

Abstract

Approximately 15% of all cerebral arteriovenous malformations (AVMs) present with progressive neurologic deficits, the pathogenic mechanism of which has not been established. One suggestion is that AVMs by expanding over time compress normal surrounding cerebral parenchyma and thereby cause progressive neurologic impairment. Alternatively, a vascular steal results in progressive ischemia of normal cerebral tissue. Because the area occupied by the AVM and the area of observed blood flow reductions in all reported patients have overlapped, delineating the relative contribution of local compression from that of vascular steal has not been possible. We present a 7-month-old girl and a 7-year-old boy with AVMs restricted to the diencephalon who had progressive cognitive impairment and dystrophic cerebral hemispheral calcification (in the 7-month-old girl) indicating diffuse cerebral cortical involvement remote from the AVM. These patients provide evidence for vascular steal, and not local compression, as the primary mechanism underlying a progressive neurologic course associated with some AVMs.

Entities:  

Mesh:

Year:  1995        PMID: 8771176     DOI: 10.1016/0887-8994(95)00220-0

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  2 in total

1.  Unilateral subcortical calcification: a manifestation of dural arteriovenous fistula.

Authors:  Ming-Shiang Yang; Clayton Chi-Chang Chen; Yung-Yi Cheng; Da-Ming Yeh; San-Kan Lee; Yeu-Sheng Tyan
Journal:  AJNR Am J Neuroradiol       Date:  2005-05       Impact factor: 3.825

2.  Partially reversible quadruple sectoranopia caused by vascular steal due to an arteriovenous malformation.

Authors:  Eric Denion; Sabine Defoort-Dhellemmes; Carl-Friedrich Arndt; Jean-Yves Gauvrit; Serge Blond; Jean-Claude Hache
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-06-22       Impact factor: 3.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.